Burning Rock Biotech (BNR) Inventory Average (2020 - 2025)

Burning Rock Biotech's Inventory Average history runs 6 years deep, the most recent figure standing at $7.2 million for Q4 2025.

• In Q4 2025, Inventory Average fell 14.47% year-over-year to $7.2 million; the TTM figure through Dec 2025 stood at $7.2 million (down 14.47% YoY), while the FY2025 annual figure was $7.8 million, down 15.16% from the prior year.
• Inventory Average was $7.2 million for Q4 2025 at Burning Rock Biotech, down from $7.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $20.3 million in Q3 2022 to a low of $7.2 million in Q4 2025.
• Historically, Inventory Average has averaged $13.5 million across 5 years, with a median of $12.8 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Inventory Average surged 81.27% in 2021, then plunged 47.5% in 2024.
• A 5-year view of Inventory Average shows it stood at $18.6 million in 2021, then gained by 5.99% to $19.7 million in 2022, then slumped by 45.67% to $10.7 million in 2023, then declined by 20.95% to $8.5 million in 2024, then declined by 14.47% to $7.2 million in 2025.
• The last three Inventory Average figures came in at $7.2 million (Q4 2025), $7.9 million (Q3 2025), and $8.5 million (Q2 2025), per Business Quant data.